A detailed history of Bordeaux Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bordeaux Wealth Advisors LLC holds 650 shares of LLY stock, worth $594,470. This represents 0.17% of its overall portfolio holdings.

Number of Shares
650
Previous 695 6.47%
Holding current value
$594,470
Previous $405,000 24.69%
% of portfolio
0.17%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$592.2 - $792.28 $26,649 - $35,652
-45 Reduced 6.47%
650 $505,000
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $46,216 - $54,483
88 Added 14.5%
695 $405,000
Q3 2023

Oct 27, 2023

BUY
$434.7 - $599.3 $44,774 - $61,727
103 Added 20.44%
607 $326,000
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $176,772 - $236,365
504 New
504 $236,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bordeaux Wealth Advisors LLC Portfolio

Follow Bordeaux Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bordeaux Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bordeaux Wealth Advisors LLC with notifications on news.